Izon Science
www.izon.comIzon Science has redefined how nano-biologicals are isolated and analysed. Izon's products are in use in a growing number of leading universities and research institutions, in over 50 countries around the world. The new Exoid instrument can measure particle size, concentration and surface charge with unparalleled precision. The qEV isolation system is used by an increasing number of life science researchers to isolate extracellular vesicles from complex biological fluids and cell cultures. The size-tunable nanopore-based detection provides a revolutionary non-optical approach to particle measurement. The size, concentration, interactions and charge of particles can be detected with individual particle resolution. Izon is advancing research in a wide range of fields which require accurate particle characterization, including: drug delivery research (drug delivery particles & liposomes), haematology (exosomes & microparticles), and virus quantitation and analysis (gene therapy vectors, viral vaccines). Head offices are in the United States (Cambridge, MA), France (Lyon) and New Zealand (Christchurch).
Read moreIzon Science has redefined how nano-biologicals are isolated and analysed. Izon's products are in use in a growing number of leading universities and research institutions, in over 50 countries around the world. The new Exoid instrument can measure particle size, concentration and surface charge with unparalleled precision. The qEV isolation system is used by an increasing number of life science researchers to isolate extracellular vesicles from complex biological fluids and cell cultures. The size-tunable nanopore-based detection provides a revolutionary non-optical approach to particle measurement. The size, concentration, interactions and charge of particles can be detected with individual particle resolution. Izon is advancing research in a wide range of fields which require accurate particle characterization, including: drug delivery research (drug delivery particles & liposomes), haematology (exosomes & microparticles), and virus quantitation and analysis (gene therapy vectors, viral vaccines). Head offices are in the United States (Cambridge, MA), France (Lyon) and New Zealand (Christchurch).
Read moreCountry
City (Headquarters)
Christchurch
Industry
Founded
2005
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Operations Officer
Email ****** @****.comPhone (***) ****-****General Manager - Americas
Email ****** @****.comPhone (***) ****-****Business Development Director ( Emea )
Email ****** @****.comPhone (***) ****-****Director of Sales - Americas
Email ****** @****.comPhone (***) ****-****
Technologies
(73)